Tag: Bioscience Neutraceuticals

Paul Levenson, Director of the SEC’s Boston Regional Office commented: Microcap stocks can be particularly vulnerable to manipulative schemes, and investors should be alert to the heightened risks that exist during this national emergency. The SEC will continue to act quickly to protect investors from investment scams, including those seeking to capitalize on the COVID-19…